
Aviceda Therapeutics
Harnessing the natural immune system to modulate inflammation with highly selective ligands targeting specific immune cells and diseases.
Employees
Enterprise value
$830m—1.2b
Authorizing premium user...
Harnessing the natural immune system to modulate inflammation with highly selective ligands targeting specific immune cells and diseases.